Clinical Trial Update: Cardiovascular Immaturity in Extremely Low Gestational Age Newborns: a Fundamental Prospective Study

View source ↗

Summary

This clinical trial update outlines a fundamental prospective study evaluating cardiovascular immaturity in extremely low gestational age newborns (ELGANs) to b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extremely Preterm Birth Complications
• Neonatal Cardiovascular Disorders

Snippet

Sponsor: University Hospital, Montpellier | Conditions: ELGAN (22-28SA), Extremely Low Gestational Age Newborns | Status: NOT_YET_RECRUITING